Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Active surveillance of prostate cancer
    Bolenz, Christian
    Grimm, Marc-Oliver
    Heidenreich, Axel
    Kristiansen, Glen
    Schimmoeller, Lars
    Schmidt, Stefanie
    Schostak, Martin
    Hadaschik, Boris
    UROLOGIE, 2025,
  • [12] Active surveillance for prostate cancer
    Graefen, M.
    Ahyai, S.
    Heuer, R.
    Salomon, G.
    Schlomm, T.
    Isbarn, H.
    Budaeus, L.
    Heinzer, H.
    Huland, H.
    UROLOGE, 2008, 47 (03): : 261 - 269
  • [13] Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients
    Shankar, Prasad R.
    Maturen, Katherine E.
    George, Arvin K.
    Borza, Tudor
    Ellimoottil, Chandy
    Montgomery, Jeffrey S.
    Wei, John T.
    Denton, Brian T.
    Davenport, Matthew S.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2019, 16 (10) : 1385 - 1392
  • [14] IMPACT OF SERIAL PROSTATE BIOPSIES ON SEXUAL FUNCTION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Glass, Allison S.
    Hilton, Joan F.
    Blaschko, Sarah D.
    Whitson, Jared M.
    Cowan, Janet E.
    Washington, Samuel L.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E587 - E587
  • [15] IMPACT OF COMPLIANCE ON OUTCOMES FOR PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Detsky, Jay
    Ghiam, Alireza Fotouhi
    Klotz, Laurence
    Liu, Stanley
    Loblaw, Andrew
    Vesprini, Danny
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S8 - S9
  • [16] Impact of active surveillance for prostate cancer on the risk of depression and anxiety
    Sypre, Davidson
    Pignot, Geraldine
    Touzani, Rajae
    Marino, Patricia
    Walz, Jochen
    Rybikowski, Stanislas
    Maubon, Thomas
    Branger, Nicolas
    Salem, Naji
    Mancini, Julien
    Gravis, Gwenaelle
    Bendiane, Marc-Karim
    Bouhnik, Anne-Deborah
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [17] Impact of active surveillance for prostate cancer on the risk of depression and anxiety
    Davidson Sypre
    Géraldine Pignot
    Rajae Touzani
    Patricia Marino
    Jochen Walz
    Stanislas Rybikowski
    Thomas Maubon
    Nicolas Branger
    Naji Salem
    Julien Mancini
    Gwenaelle Gravis
    Marc-Karim Bendiane
    Anne-Deborah Bouhnik
    Scientific Reports, 12
  • [18] Active surveillance for prostate cancer: is it too active?
    Ehdaie, Behfar
    BJU INTERNATIONAL, 2016, 118 (03) : 343 - 343
  • [19] MRI and Active Surveillance for Prostate Cancer
    Porreca, Angelo
    Colicchia, Michele
    Busetto, Gian Maria
    Ferro, Matteo
    DIAGNOSTICS, 2020, 10 (08)
  • [20] The economics of active surveillance for prostate cancer
    Dall'Era, Marc A.
    CURRENT OPINION IN UROLOGY, 2013, 23 (03) : 278 - 282